RFX1's Role in Regulating Immune Genes in Lupus T Cells
Author Information
Author(s): Zhao Ming, Wu Xiaoyan, Zhang Qing, Luo Shuangyan, Liang Gongping, Su Yuwen, Tan Yixin, Lu Qianjin
Primary Institution: Second Xiangya Hospital, Central South University
Hypothesis
Is RFX1 involved in regulating histone methylation at the CD11a and CD70 promoters in SLE CD4+ T cells?
Conclusion
RFX1 regulates the expression of CD11a and CD70 in lupus T cells by recruiting SUV39H1, which affects histone methylation levels.
Supporting Evidence
- RFX1 down-regulation leads to increased CD11a and CD70 expression in SLE CD4+ T cells.
- H3K9 tri-methylation levels are significantly reduced in SLE CD4+ T cells compared to healthy controls.
- RFX1 interacts with SUV39H1, which is involved in histone methylation at the CD11a and CD70 promoters.
Takeaway
RFX1 helps control certain genes in immune cells, and when it's not working properly in lupus patients, those genes can become overactive.
Methodology
CD4+ T cells were isolated from 15 SLE patients and 15 healthy controls, and various assays were performed to measure histone methylation and gene expression.
Potential Biases
Potential bias in patient selection and the influence of external factors on gene expression.
Limitations
The study is limited to a specific patient population and may not generalize to all lupus patients.
Participant Demographics
SLE patients (mean age 27 ± 6 years) and healthy controls (mean age 25 ± 3 years), age- and sex-matched.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website